12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Company News  |  Deals

Karo Bio, Pfizer deal

Karo Bio and Pfizer extended to the end of 2014 their 2011 deal to discover and develop small molecule RAR-related orphan receptor C...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >